CRISPR Therapeutics (CRSP) PT Raised to $187 at Oppenheimer

February 17, 2021 6:18 AM EST Send to a Friend

Oppenheimer analyst Jay Olson raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

CRISPR Therapeutics (CRSP) PT Raised to $187 at Oppenheimer

Member Login

Free News Feed